Navigation Links
New AIDS vaccine may be in the offing

An article published in an online issue of Nature Medicine by researchers in Rene Descartes University has reported a stunning discovery of a bold new type of vaccine which may one day let people quit their AIDS drugs. The study which was carried// out on monkeys showed promising results, and if confirmed and adapted in humans may signal a major new therapeutic approach to HIV.

The researchers reported that the new vaccine uses a type of cell, commonly found in the skin, called dendritic cells or DCs. The main job of DCs is to grab foreign substances and turn them in to the immune system, which triggers a chain reaction that starts a powerful immune attack on similar substances. In the study, the researchers injected these cells (i.e. DCs) that were loaded with a killed AIDS virus into monkeys, infected with the same virus. The monkeys which would quickly die in normal conditions, were alive and did not get sick - at least for the 34-week study period, when they were given the vaccine treatment.

Most vaccines make the immune system do one of two things: make antibodies or make germ-killing cells while the DC vaccine elicited both kinds of immune responses. Researchers claim that these therapeutic approaches which used inactivated-virus-loaded DC vaccines to generate strong HIV-specific cellular and antibody immunities may result in long-term immunological control of chronic HIV disease. However, a major question which needs to be resolved is that of how long the vaccine-stimulated immune responses will keep the AIDS virus under control.


'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... , ... June 23, 2017 , ... MD Now ... This is MD Now’s 28th facility overall and marks the urgent care center's eighth ... one mile North of The Falls shopping mall. The new clinic offers a wide ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ... the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people ... the Biggert-Waters Act was enacted to reflect the actual risk in flood zone ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... assistance and financial planning services to communities in the greater Chicago metropolitan area, ... to offer assistance to underprivileged youth in Chicago. , Founded in 1897, Hephzibah ...
(Date:6/23/2017)... Morgantown, WV (PRWEB) , ... June 23, 2017 ... ... asset protection services and personal financial planning to families and business owners in ... Stepping Stones organization to help provide services to differently abled residents in the ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: